Cargando…

Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy

BACKGROUND: Inconsistent diagnostic test accuracies of immunohistological staining for squamous cell carcinoma (SQC) of the lung have been frequently reported. There have been few meta-analyses of the diagnostic accuracies of the immunohistochemical markers. METHODS: A systematic review and meta-ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Hao, Katakura, Seigo, Horita, Nobuyuki, Namkoong, Ho, Kato, Ikuma, Hara, Yu, Kobayashi, Nobuaki, Fujii, Satoshi, Kaneko, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814972/ https://www.ncbi.nlm.nih.gov/pubmed/35126682 http://dx.doi.org/10.1177/17588359211065152

Ejemplares similares

The best regimens for chemo-naïve incurable non-squamous non-small cell lung cancer with a programmed death-ligand 1, tumor proportion score 1–49%: a network meta-analysis
por: Fukuda, Nobuhiko, et al.
Publicado: (2021)

Hydroxychloroquine and chloroquine for treatment of coronavirus disease 19 (COVID-19): a systematic review and meta-analysis of randomized and non-randomized controlled trials
por: Ebina-Shibuya, Risa, et al.
Publicado: (2021)

Best regimens for treating chemo‐naïve incurable squamous non‐small cell lung cancer with a programmed death‐ligand 1 tumor proportion score of 1%–49%: A network meta‐analysis
por: Fukuda, Nobuhiko, et al.
Publicado: (2021)

Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non‐small cell lung cancer patients: A meta‐analysis
por: Kobayashi, Nobuaki, et al.
Publicado: (2021)

Clinical features of asthma with connective tissue diseases
por: Watanabe, Keisuke, et al.
Publicado: (2023)

Hazard ratio of progression-free survival is an excellent predictor of overall survival in phase III randomized controlled trials evaluating the first-line chemotherapy for extensive-disease small-cell lung cancer
por: Chen, Hao, et al.
Publicado: (2020)

Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis
por: Chen, Hao, et al.
Publicado: (2021)

Elderly sarcoidosis in Japan
por: Masumoto, Nami, et al.
Publicado: (2022)

T‐cell response to phytohemagglutinin in the interferon‐γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non‐small cell lung cancer
por: Kamimaki, Chisato, et al.
Publicado: (2021)

Non‐small cell lung cancer with mesenchymal–epithelial transition gene exon 14 skipping mutation treated with crizotinib
por: Katakura, Seigo, et al.
Publicado: (2019)

Adverse events induced by nivolumab and ipilimumab combination regimens
por: Somekawa, Kohei, et al.
Publicado: (2022)

MicroRNA‐200b is a potential biomarker of the expression of PD‐L1 in patients with lung cancer
por: Katakura, Seigo, et al.
Publicado: (2020)

Current national policies for infant universal bacille Calmette-Guérin vaccination were associated with lower mortality from coronavirus disease 2019
por: Ebina-Shibuya, Risa, et al.
Publicado: (2020)

Disease control and objective responsive rates in randomized phase II trials evaluating non-first-line chemotherapy for non-small cell lung cancer: a systematic review of 74 trials
por: Matsumoto, Hiromi, et al.
Publicado: (2021)

Prophylactic antibiotics for postcataract surgery endophthalmitis: a systematic review and network meta-analysis of 6.8 million eyes
por: Kato, Ai, et al.
Publicado: (2022)

Assessment of diagnostic utility of serum hemeoxygenase-1 measurement for acute exacerbation of interstitial pneumonias
por: Kata, Yuki, et al.
Publicado: (2022)

Diagnostic test accuracy of glutamate dehydrogenase for Clostridium difficile: Systematic review and meta-analysis
por: Arimoto, Jun, et al.
Publicado: (2016)

Diagnostic test accuracy of D-dimer for acute aortic syndrome: systematic review and meta-analysis of 22 studies with 5000 subjects
por: Watanabe, Hiroki, et al.
Publicado: (2016)

Diagnostic utility of transbronchial biopsy for Hodgkin's lymphoma: A case study
por: Hoshi, Miki, et al.
Publicado: (2021)

Inhaled Corticosteroid and Secondary Glaucoma: A Meta-analysis of 18 Studies
por: Ishii, Mai, et al.
Publicado: (2021)

Afatinib + bevacizumab combination therapy in EGFR‐mutant NSCLC patients with osimertinib resistance: Protocol of an open‐label, phase II, multicenter, single‐arm trial
por: Kobayashi, Nobuaki, et al.
Publicado: (2020)

Clinical importance of serum heme oxygenase-1 measurement in patients with acute exacerbation of idiopathic pulmonary fibrosis triggered by coronavirus disease 2019
por: Hara, Yu, et al.
Publicado: (2022)

ILD-GAP Combined with the Charlson Comorbidity Index Score (ILD-GAPC) as a Prognostic Prediction Model in Patients with Interstitial Lung Disease
por: Fujii, Hiroaki, et al.
Publicado: (2023)

Unusual lung involvements of invasive mucinous adenocarcinoma with chylothorax
por: Aoki, Ayako, et al.
Publicado: (2020)

Clinical Features and Risk Factors for Mortality in Hospitalized Older Adults with Pneumonia
por: Fukuda, Nobuhiko, et al.
Publicado: (2021)

Real-World Diagnostic Accuracy and Use of Immunohistochemical Markers in Lung Cancer Diagnostics
por: Ericson Lindquist, Kajsa, et al.
Publicado: (2021)

Class A CpG oligodeoxynucleotide inhibits IFN‐γ‐induced signaling and apoptosis in lung cancer
por: Teranishi, Shuhei, et al.
Publicado: (2020)

Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysis
por: Chen, Hao, et al.
Publicado: (2020)

Role of combined indacaterol and glycopyrronium bromide (QVA149) for the treatment of COPD in Japan
por: Horita, Nobuyuki, et al.
Publicado: (2015)

Genetic model selection for a case–control study and a meta-analysis
por: Horita, Nobuyuki, et al.
Publicado: (2015)

Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial
por: Horita, Nobuyuki, et al.
Publicado: (2020)

An Early Screening Tool for Discharge Planning Shortened Length of Hospital Stay for Elderly Patients with Community-Acquired Pneumonia
por: Chen, Hao, et al.
Publicado: (2021)

Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in Japan
por: Matsumoto, Hiromi, et al.
Publicado: (2023)

The clinical impact of comorbidities among patients with idiopathic pulmonary fibrosis undergoing anti-fibrotic treatment: A multicenter retrospective observational study
por: Aoki, Ayako, et al.
Publicado: (2023)

＜Editors’ Choice＞ Comparison of clinical features between patients with acute exacerbation of idiopathic interstitial pneumonia and collagen vascular disease-associated interstitial pneumonia
por: Kata, Yuki, et al.
Publicado: (2023)

Declined Functional Status Prolonged Hospital Stay for Community-Acquired Pneumonia in Seniors
por: Chen, Hao, et al.
Publicado: (2020)

Is rehabilitation effective in preventing decreased functional status after community-acquired pneumonia in elderly patients? Results from a multicentre, retrospective observational study
por: Chen, Hao, et al.
Publicado: (2022)

The triple therapy for chronic obstructive pulmonary disease increases the risk of pneumonias compared to the dual-bronchodilator therapy
por: Watanabe, Keisuke, et al.
Publicado: (2021)

The Extent of Honeycombing on Computed Tomography Cannot Predict the Treatment Outcome of Patients with Acute Exacerbations of Interstitial Lung Disease
por: Nishikawa, Yurika, et al.
Publicado: (2021)

KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer
por: Chen, Hao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qsmiaegd6ko795sfd78ltdm5uu